$RGBP "Should HemaXellerate be fortunate enough t
Post# of 18244
Posted On: 09/22/2016 10:15:26 AM
$RGBP "Should HemaXellerate be fortunate enough to be designated an Orphan Drug, we will take advantage of the rich resources the National Institutes of Health provides in assisting development of such drugs to get HemaXellerate to market as quickly as possible," said Harry Lander, Ph.D., MBA, President and Chief Scientific Officer of Regen BioPharma.
https://finance.yahoo.com/news/regen-biopharm...00009.html
https://finance.yahoo.com/news/regen-biopharm...00009.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼